Lee Biosolutions Achieves FDA Registration

Published: Apr 27th, 2006

Leading Manufacturer of Renin and MPO Announces Registration with the U.S. Food and Drug Administration

August 23, 2005; St. Louis, Missouri - Lee Biosolutions was recently registered with the United States Food and Drug Administration as a medical materials producer. Registration provides the FDA with the location of medical device manufacturing facilities and importers.

While Lee Bio was not required to register with the FDA by law, President Burton Lee said the company decided to register as a means of keeping up with the requirements and regulations that his customers must comply with.

"Registration helps us keep an eye on the rules that our customers are required to adhere to." Lee said. "It enables us to establish our business processes in line with our customers' requirements to better meet their needs."

Lee Biosolutions customers are research labs across the country that rely on the raw materials that Lee Bio provides in the development of tomorrow's cures.

Lee Biosolutions is known as a leading manufacturer of renin and myeloperoxidase (MPO). Renin is an enzyme used in the diagnosis and treatment of cardiovascular diseases. MPO is a marker used in the detection of acute myocardial infarction, and the differentiation between myeloid and lymphoid leukemia.

Lee Biosolutions is a leader in the biomaterials industry, providing quality biomaterial products to clinical labs and researchers around the world, developing tomorrows cures. Leebio has provided human proteins used in a number of high profile biomarker studies. For more information or to place an order,contact:

Lee Biosolutions, Inc
2924 Mary Ave
St. Louis, MO 63144
Tel:314-968-1091
www.leebio.com